Linezolid Tolerance During the BPaL Regimen With Dosage Personalization Based on Therapeutic Drug Monitoring (TDM) During Multidrug-Resistant Tuberculosis Treatment

Abroad (travel likely)RecruitingPHASE4

Conditions

Linezolid · Tuberculosis Multi Drug Resistant Active · Therapeutic Drug Monitoring (TDM)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Centre de Santé de Tombolia, Conakry, Guinea
Contact: Study coordinator (Souleymane Hassane Harouna) · hassoul20@yahoo.fr · +224620717593

Study leads

Marco Schiuma
Study Director
ASST Fatebenefratelli Sacco, Luigi Sacco University Hospital, Milan, Italy
Souleymane Hassane Harouna
Principal Investigator
Action Daminen Guinée

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis

Tuberculosis, Pulmonary · Tuberculosis, Multidrug-Resistant · Tuberculosis, MDR

Abroad (travel likely)RecruitingPHASE2, PHASE3

Ulaanbaatar, Mongolia · Kotri, Pakistan

Sorfequiline-based Regimens in Adults With Newly Diagnosed Drug-sensitive Pulmonary TB

Tuberculosis, Pulmonary

Abroad (travel likely)RecruitingPHASE2

Port Elizabeth, South Africa · Pretoria, South Africa

Evaluation of the Early Bactericidal Activity of Tedizolid and Linezolide Against Mycobacterium Tuberculosis (TEDITUB)

Tuberculosis · Multidrug Resistant Tuberculosis

Abroad (travel likely)RecruitingPHASE2

Paris, France